You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美國FDA批准強生(JNJ.US)和聯想生物技術公司的癌症治療方案
格隆匯3月1日丨週一,美國強生(JNJ.US)宣佈,美國衞生監管機構已批准其與中國合作伙伴傳奇生物技術公司(LEGN.US)開發的一種治療一種白細胞癌的療法。傳奇生物技術公司CEO兼首席財務官表示,這是公司計劃為患者提供的眾多細胞療法中的第一種,將繼續推進針對不同疾病的治療管道。這種名為Carvykti/Cilta-cel的療法屬於CAR-T療法的一類藥物,即嵌合抗原受體t細胞療法。CAR-T藥物的工作原理是收集患者自身的抗病t細胞,通過基因工程改造它們,使其針對癌細胞上的特定蛋白質,然後替換它們,尋找並攻擊癌症。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account